Curis (CRIS) FFO


CRIS Curis Inc CRIS
54 GF Score
Price $0.31
GF Value $1.04
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Curis FFO?

FFO (Funds from operations) only applies to REITs.

CRIS
54GF Score
Curis Inc CRIS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Curis (CRIS) Overvalued in 2026?

Based on GuruFocus' analysis, Curis stock appears to be undervalued. The current stock price of $0.31 is trading 69.8% below its estimated GF Value™ of $1.04. GuruFocus considers Curis to be Possible Value Trap.

Key valuation signals for CRIS:

  • FFO:
  • GF Value™: $1.04 vs. price of $0.31 (69.8% below fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the CRIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Curis Business Description

Other Exchanges CUS0:Germany
Address 128 Spring Street, Building C - Suite 500, Lexington, MA, USA, 02421
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
54GF Score

Get the complete analysis for CRIS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.31
Price
$1.04
GF Value